Inflammation, metaflammation and immunometabolic disorders (original) (raw)

• Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860–867 (2006)
  Article CAS PubMed ADS Google Scholar
• Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633–643 (2013)
  CAS PubMed PubMed Central Google Scholar
• Kotas, M. E. & Medzhitov, R. Homeostasis, inflammation, and disease susceptibility. Cell 160, 816–827 (2015)
  Article CAS PubMed PubMed Central Google Scholar
• Agrawal, N. et al. The Drosophila TNF Eiger is an adipokine that acts on insulin-producing cells to mediate nutrient response. Cell Metab. 23, 675–684 (2016).An important study demonstrating the evolutionary conservation of the negative impact of TNF on insulin production, insulin action and glucose metabolism, and a demonstration of how cytokines can serve as metabolic hormones.
  Article CAS PubMed Google Scholar
• Mabery, E. M. & Schneider, D. S. The Drosophila TNF ortholog Eiger is required in the fat body for a robust immune response. J. Innate Immun. 2, 371–378 (2010)
  Article CAS PubMed PubMed Central Google Scholar
• Wang, M. C., Bohmann, D. & Jasper, H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121, 115–125 (2005)
  Article CAS PubMed Google Scholar
• DiAngelo, J. R., Bland, M. L., Bambina, S., Cherry, S. & Birnbaum, M. J. The immune response attenuates growth and nutrient storage in Drosophila by reducing insulin signaling. Proc. Natl Acad. Sci. USA 106, 20853–20858 (2009)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Hull-Thompson, J. et al. Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. PLoS Genet. 5, e1000460 (2009)
  Article PubMed PubMed Central CAS Google Scholar
• Pasco, M. Y. & Léopold, P. High sugar-induced insulin resistance in Drosophila relies on the lipocalin Neural Lazarillo. PLoS One 7, e36583 (2012)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Morris, S. N. et al. Development of diet-induced insulin resistance in adult Drosophila melanogaster. Biochim. Biophys. Acta 1822, 1230–1237 (2012)
  Article CAS PubMed PubMed Central Google Scholar
• Pekala, P., Kawakami, M., Vine, W., Lane, M. D. & Cerami, A. Studies of insulin resistance in adipocytes induced by macrophage mediator. J. Exp. Med. 157, 1360–1365 (1983).This important paper demonstrates that macrophages activated by LPS secrete products that block insulin action in adipocytes.
  Article CAS PubMed Google Scholar
• Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993)
  Article CAS PubMed ADS Google Scholar
• Uysal, K. T., Wiesbrock, S. M., Marino, M. W. & Hotamisligil, G. S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610–614 (1997)
  Article CAS PubMed ADS Google Scholar
• Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830 (2003)
  Article CAS PubMed PubMed Central Google Scholar
• Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003).Published simultaneously, these two important studies (refs 14 and 15 ) demonstrated macrophage infiltration into adipose tissue and relate this to metabolic deterioration.
  Article CAS PubMed PubMed Central Google Scholar
• Hausberger, F. X. Pathological changes in adipose tissue of obese mice. Anat. Rec. 154, 651–660 (1966)
  Article CAS PubMed Google Scholar
• Hellman, B. Studies in obese-hyperglycemic mice. Ann. NY Acad. Sci. 131, 541–558 (1965)
  Article CAS PubMed ADS Google Scholar
• Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007)
  Article CAS PubMed PubMed Central Google Scholar
• Nguyen, M. T. et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282, 35279–35292 (2007)
  Article CAS PubMed Google Scholar
• Hevener, A. L. et al. Macrophage PPARg is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 117, 1658–1669 (2007)
  Article CAS PubMed PubMed Central Google Scholar
• Fan, R. et al. Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes. Nat. Med. 22, 780–791 (2016)
  Article CAS PubMed ADS Google Scholar
• Li, P. et al. Hematopoietic-derived Galectin-3 causes cellular and systemic insulin resistance. Cell 167, 973–984.e12 (2016)
  Article CAS PubMed PubMed Central Google Scholar
• Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408–415 (2011)
  Article CAS PubMed PubMed Central Google Scholar
• Stienstra, R. et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12, 593–605 (2010)
  Article CAS PubMed PubMed Central Google Scholar
• Herder, C., Dalmas, E., Böni-Schnetzler, M. & Donath, M. Y. The IL-1 pathway in type 2 diabetes and cardiovascular complications. Trends Endocrinol. Metab. 26, 551–563 (2015)
  Article CAS PubMed Google Scholar
• Larsen, C. M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517–1526 (2007).A critical study demonstrating the benefits of blocking inflammation in humans with type 2 diabetes.
  Article CAS PubMed Google Scholar
• Song, F. et al. RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice. Diabetes 63, 1948–1965 (2014)
  Article CAS PubMed PubMed Central Google Scholar
• Montes, V. N. et al. Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet. Nutr. Diabetes 5, e161 (2015)
  Article CAS PubMed PubMed Central Google Scholar
• Lu, B. et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670–674 (2012)
  Article CAS PubMed PubMed Central ADS Google Scholar
• He, Y., Franchi, L. & Núñez, G. The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages. Eur. J. Immunol. 43, 1147–1152 (2013)
  Article CAS PubMed PubMed Central Google Scholar
• Boriushkin, E., Wang, J. J., Li, J., Bhatta, M. & Zhang, S. X. p58IPK suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages. Sci. Rep. 6, 25013 (2016)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Li, W., Li, J., Sama, A. E. & Wang, H. Carbenoxolone blocks endotoxin-induced protein kinase R (PKR) activation and high mobility group Box 1 (HMGB1) release. Mol. Med. 19, 203–211 (2013)
  Article CAS PubMed PubMed Central Google Scholar
• Hett, E. C. et al. Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat. Chem. Biol. 9, 398–405 (2013)
  Article CAS PubMed PubMed Central Google Scholar
• Xie, M. et al. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat. Commun. 7, 13280 (2016).This study demonstrates the importance of PKR in inflammasome activation, and how cellular metabolism influences this activity.
  Article CAS PubMed PubMed Central ADS Google Scholar
• Youssef, O. A. et al. Potential role for snoRNAs in PKR activation during metabolic stress. Proc. Natl Acad. Sci. USA 112, 5023–5028 (2015)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Michel, C. I. et al. Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab. 14, 33–44 (2011).A paper demonstrating the critical role of small nucleolar RNAs in mediating the detrimental effects of metabolic stress, particularly in response to lipids.
  Article CAS PubMed PubMed Central Google Scholar
• Fu, S., Watkins, S. M. & Hotamisligil, G. S. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 15, 623–634 (2012)
  Article CAS PubMed Google Scholar
• Lancaster, G. I. et al. PKR is not obligatory for high-fat diet-induced obesity and its associated metabolic and inflammatory complications. Nat. Commun. 7, 10626 (2016)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Hage Hassan, R. et al. Sustained action of ceramide on the insulin signaling pathway in muscle cells: implication of the double-stranded RNA-activated protein kinase. J. Biol. Chem. 291, 3019–3029 (2016)
  Article PubMed CAS Google Scholar
• Chen, S. S. et al. Activation of double-stranded RNA-dependent protein kinase inhibits proliferation of pancreatic β-cells. Biochem. Biophys. Res. Commun. 443, 814–820 (2014)
  Article CAS PubMed Google Scholar
• Song, Y. et al. Activated PKR inhibits pancreatic β-cell proliferation through sumoylation-dependent stabilization of P53. Mol. Immunol. 68 (2 Pt A), 341–349 (2015)
  Article CAS PubMed Google Scholar
• Yang, H. et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 185, 1836–1845 (2010)
  Article CAS PubMed Google Scholar
• Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930–939 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Winer, S. et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921–929 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Ilan, Y. et al. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc. Natl Acad. Sci. USA 107, 9765–9770 (2010)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Bapat, S. P. et al. Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature 528, 137–141 (2015)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Cipolletta, D. et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549–553 (2012).This paper demonstrates that an established anti-diabetic agent produces its anti-inflammatory and anti-diabetic effects through PPARγ n T reg cells.
  Article CAS PubMed PubMed Central ADS Google Scholar
• Winer, D. A. et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17, 610–617 (2011)
  Article CAS PubMed PubMed Central Google Scholar
• DeFuria, J. et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl Acad. Sci. USA 110, 5133–5138 (2013)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Nishimura, S. et al. Adipose natural regulatory B cells negatively control adipose tissue inflammation. Cell Metab. 18, 759–766 (2013)
  Article CAS PubMed Google Scholar
• Ji, Y. et al. Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J. Biol. Chem. 287, 13561–13571 (2012)
  Article CAS PubMed PubMed Central Google Scholar
• Lynch, L. Adipose invariant natural killer T cells. Immunology 142, 337–346 (2014)
  Article CAS PubMed PubMed Central Google Scholar
• Kwon, H. et al. Adipocyte-specific IKKβ signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway. Cell Reports 9, 1574–1583 (2014).This important paper demonstrates the anti-inflammatory activity of the IKK pathway, and shows that IKK activation is not equivalent to inflammation owing to its impact on resolution in the adipose tissue.
  Article CAS PubMed Google Scholar
• Zhang, X. et al. Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61–73 (2008)
  Article CAS PubMed PubMed Central Google Scholar
• Goldfine, A. B. et al. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 159, 1–12 (2013)
  Article PubMed PubMed Central Google Scholar
• Hundal, R. S. et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 109, 1321–1326 (2002)
  Article CAS PubMed PubMed Central Google Scholar
• Gehart, H., Kumpf, S., Ittner, A. & Ricci, R. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep. 11, 834–840 (2010)
  Article CAS PubMed PubMed Central Google Scholar
• González-Terán, B. et al. p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration. EMBO J. 35, 536–552 (2016)
  Article PubMed PubMed Central CAS Google Scholar
• Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333–336 (2002)
  Article CAS PubMed ADS Google Scholar
• Tuncman, G. et al. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl Acad. Sci. USA 103, 10741–10746 (2006)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Sabio, G. et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539–1543 (2008).This manuscript shows the pathological role of JNK activity in adipose tissue and demonstrates how this inflammatory input disrupts liver insulin action and glucose metabolism. This paper also addresses the role of JNK1 in macrophages.
  Article CAS PubMed PubMed Central ADS Google Scholar
• Tsaousidou, E. et al. Distinct roles for JNK and IKK activation in Agouti-related peptide neurons in the development of obesity and insulin resistance. Cell Reports 9, 1495–1506 (2014)
  Article CAS PubMed Google Scholar
• Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900–917 (2010)
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, K. & Kaufman, R. J. From endoplasmic-reticulum stress to the inflammatory response. Nature 454, 455–462 (2008)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Keestra-Gounder, A. M. et al. NOD1 and NOD2 signalling links ER stress with inflammation. Nature 532, 394–397 (2016)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Oslowski, C. M. et al. Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab. 16, 265–273 (2012)
  Article CAS PubMed PubMed Central Google Scholar
• Bettigole, S. E. & Glimcher, L. H. Endoplasmic reticulum stress in immunity. Annu. Rev. Immunol. 33, 107–138 (2015)
  Article CAS PubMed Google Scholar
• Yang, L. et al. S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction. Science 349, 500–506 (2015)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Jurczak, M. J. et al. Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice. J. Biol. Chem. 287, 2558–2567 (2012)
  Article CAS PubMed Google Scholar
• Turner, N. & Heilbronn, L. K. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol. Metab. 19, 324–330 (2008)
  Article CAS PubMed Google Scholar
• Morino, K., Petersen, K. F. & Shulman, G. I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 (Suppl 2), S9–S15 (2006)
  Article CAS PubMed Google Scholar
• Freemerman, A. J. et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289, 7884–7896 (2014)
  Article CAS PubMed PubMed Central Google Scholar
• Miao, H. et al. Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice. Cell Reports 7, 223–235 (2014)
  Article CAS PubMed Google Scholar
• Bogacka, I., Xie, H., Bray, G. A. & Smith, S. R. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54, 1392–1399 (2005)
  Article CAS PubMed Google Scholar
• Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944–2950 (2002)
  Article CAS PubMed Google Scholar
• Arruda, A. P. et al. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med. 20, 1427–1435 (2014)
  Article CAS PubMed PubMed Central Google Scholar
• Fujita, H. et al. The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1β. EMBO J. 34, 1042–1055 (2015)
  Article CAS PubMed PubMed Central Google Scholar
• Arruda, A. P. & Hotamisligil, G. S. Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes. Cell Metab. 22, 381–397 (2015)
  Article CAS PubMed PubMed Central Google Scholar
• Randle, P. J., Garland, P. B., Hales, C. N. & Newsholme, E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281, 785–789 (1963)
  Article Google Scholar
• McGarry, J. D. Glucose-fatty acid interactions in health and disease. Am. J. Clin. Nutr. 67 (Suppl), 500S–504S (1998)
  Article CAS PubMed Google Scholar
• Glass, C. K. & Olefsky, J. M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635–645 (2012)
  Article CAS PubMed PubMed Central Google Scholar
• Nguyen, M. T. et al. JNK and tumor necrosis factor-a mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 280, 35361–35371 (2005). This paper demonstrates that FFAs induce insulin resistance in cells by activating inflammatory cascades involving JNK and IKK.
  Article CAS PubMed Google Scholar
• Tynan, G. A. et al. Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammation. Diabetes 63, 2037–2050 (2014)
  Article CAS PubMed Google Scholar
• Yu, C. et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230–50236 (2002)
  Article CAS PubMed Google Scholar
• Lee, J. Y. et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278, 37041–37051 (2003)
  Article CAS PubMed Google Scholar
• Huang, S. et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 53, 2002–2013 (2012)
  Article CAS PubMed PubMed Central Google Scholar
• Davis, J. E., Gabler, N. K., Walker-Daniels, J. & Spurlock, M. E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16, 1248–1255 (2008)
  Article CAS Google Scholar
• Jin, C., Henao-Mejia, J. & Flavell, R. A. Innate immune receptors: key regulators of metabolic disease progression. Cell Metab. 17, 873–882 (2013)
  Article CAS PubMed Google Scholar
• Kleinridders, A. et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 10, 249–259 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Sampey, B. P. et al. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 7, e38812 (2012)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Lim, J. et al. Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. FASEB J. 27, 4757–4767 (2013)
  Article CAS PubMed ADS Google Scholar
• Bikman, B. T. & Summers, S. A. Ceramides as modulators of cellular and whole-body metabolism. J. Clin. Invest. 121, 4222–4230 (2011)
  Article CAS PubMed PubMed Central Google Scholar
• Griffin, M. E. et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48, 1270–1274 (1999)
  Article CAS PubMed Google Scholar
• Szendroedi, J. et al. Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc. Natl Acad. Sci. USA 111, 9597–9602 (2014).This study shows that in human subjects lipid-induced insulin resistance in muscle is associated with DAG–PKC activation.
  Article CAS PubMed PubMed Central ADS Google Scholar
• Kim, J. K. et al. PKC-θ knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114, 823–827 (2004)
  Article CAS PubMed PubMed Central Google Scholar
• Serra, C. et al. Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity. J. Cell. Physiol. 196, 89–97 (2003)
  Article CAS PubMed Google Scholar
• Kewalramani, G., Fink, L. N., Asadi, F. & Klip, A. Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C θ and ε. PLoS One 6, e26947 (2011)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Yilmaz, M., Claiborn, K. C. & Hotamisligil, G. S. De novo lipogenesis products and endogenous lipokines. Diabetes 65, 1800–1807 (2016)
  Article CAS PubMed PubMed Central Google Scholar
• Fox, M. J., Kuzma, J. F. & Washam, W. T. Transitory diabetic syndrome associated with meningococcic meningitis. Arch. Intern. Med. (Chic.) 79, 614–621 (1947)
  Article CAS Google Scholar
• Dimas, A. S. et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63, 2158–2171 (2014)
  Article MathSciNet CAS PubMed PubMed Central Google Scholar
• McCarthy, M. I. Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 363, 2339–2350 (2010)
  Article CAS PubMed Google Scholar
• Florez, J. C. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51, 1100–1110 (2008)
  Article CAS PubMed Google Scholar
• Jain, P. et al. Systems biology approach reveals genome to phenome correlation in type 2 diabetes. PLoS One 8, e53522 (2013)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44, 659–669 (2012)
  Article CAS PubMed PubMed Central Google Scholar
• Kooner, J. S. et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat. Genet. 43, 984–989 (2011)
  Article CAS PubMed PubMed Central Google Scholar
• Cho, Y. S. et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat. Genet. 44, 67–72 (2011)
  Article PubMed PubMed Central CAS Google Scholar
• Waeber, G. et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat. Genet. 24, 291–295 (2000).This paper identifies a mutation in MAPK81P1 which causes constitutive JNK activation in humans leading to a Mendelian form of diabetes.
  Article CAS PubMed Google Scholar
• Ichimura, A. et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350–354 (2012).This paper examines the role of GPR120, which was previously demonstrated by the Olefsky laboratory to be a lipid sensor critical for immunometabolism and diabetes, in human genetic studies.
  Article CAS PubMed ADS Google Scholar
• Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015)
  Article CAS PubMed PubMed Central Google Scholar
• Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015)
  Article CAS PubMed PubMed Central Google Scholar
• Brown, A. E. et al. p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab. 308, E63–E70 (2015)
  Article CAS PubMed Google Scholar
• Toubal, A., Treuter, E., Clément, K. & Venteclef, N. Genomic and epigenomic regulation of adipose tissue inflammation in obesity. Trends Endocrinol. Metab. 24, 625–634 (2013)
  Article CAS PubMed Google Scholar
• Burska, A. N., Sakthiswary, R. & Sattar, N. Effects of tumour necrosis factor antagonists on insulin sensitivity/resistance in rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 10, e0128889 (2015)
  Article PubMed PubMed Central CAS Google Scholar
• Solomon, D. H. et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. J. Am. Med. Assoc. 305, 2525–2531 (2011)
  Article CAS Google Scholar
• Donath, M. Y. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat. Rev. Drug Discov. 13, 465–476 (2014)
  Article CAS PubMed Google Scholar
• Schork, N. J. Personalized medicine: time for one-person trials. Nature 520, 609–611 (2015)
  Article CAS PubMed ADS Google Scholar
• Cerami, A. TNF and EPO: major players in the innate immune response: their discovery. Ann. Rheum. Dis. 71 (Suppl 2), i55–i59 (2012)
  Article CAS PubMed Google Scholar
• Collino, M. et al. A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice. Br. J. Pharmacol. 171, 5802–5815 (2014)
  Article CAS PubMed PubMed Central Google Scholar
• Brines, M. et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol. Med. 20, 658–666 (2015)
  Article PubMed PubMed Central Google Scholar
• Kothari, V., Galdo, J. A. & Mathews, S. T. Hypoglycemic agents and potential anti-inflammatory activity. J. Inflamm. Res. 9, 27–38 (2016)
  CAS PubMed PubMed Central Google Scholar
• Scheen, A. J., Esser, N. & Paquot, N. Antidiabetic agents: potential anti-inflammatory activity beyond glucose control. Diabetes Metab. 41, 183–194 (2015)
  Article CAS PubMed Google Scholar
• Lancaster, G. I. & Febbraio, M. A. The immunomodulating role of exercise in metabolic disease. Trends Immunol. 35, 262–269 (2014)
  Article CAS PubMed Google Scholar
• Coward, W. R., Marei, A., Yang, A., Vasa-Nicotera, M. M. & Chow, S. C. Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes. J. Immunol. 176, 5284–5292 (2006)
  Article CAS PubMed Google Scholar
• Henriksbo, B. D. et al. Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance. Diabetes 63, 3742–3747 (2014).This study demonstrates a direct link between a statin and inflammasome activation, showing a mechanism by which statins may act as pro-inflammatory agents.
  Article CAS PubMed Google Scholar
• Nishimoto, S. et al. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci. Adv. 2, e1501332 (2016)
  Article PubMed PubMed Central ADS CAS Google Scholar
• Lefere, S. et al. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease. Cell. Mol. Life Sci. 73, 3419–3431 (2016)
  Article CAS PubMed Google Scholar
• Minamino, T. et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15, 1082–1087 (2009)
  Article CAS PubMed Google Scholar
• Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153–162 (2012)
  Article CAS PubMed Google Scholar
• Wernstedt Asterholm, I. et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 20, 103–118 (2014)
  Article CAS PubMed Google Scholar
• Vereecke, L. et al. A20 controls intestinal homeostasis through cell-specific activities. Nat. Commun. 5, 5103 (2014)
  Article CAS PubMed ADS Google Scholar
• Yi, Z., Stunz, L. L. & Bishop, G. A. CD40-mediated maintenance of immune homeostasis in the adipose tissue microenvironment. Diabetes 63, 2751–2760 (2014)
  Article CAS PubMed PubMed Central Google Scholar
• Li, Y. et al. A functional genomics approach to understand variation in cytokine production in humans. Cell 167, 1099–1110.e14 (2016)
  Article CAS PubMed Google Scholar
• ter Horst, R. et al. Host and environmental factors influencing individual human cytokine responses. Cell 167, 1111–1124.e13 (2016)
  Article CAS PubMed PubMed Central Google Scholar
• Schirmer, M. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167, 1125–1136.e8 (2016)
  Article CAS PubMed PubMed Central Google Scholar
• Bogue, M. A., Churchill, G. A. & Chesler, E. J. Collaborative cross and diversity outbred data resources in the Mouse Phenome Database. Mamm. Genome 26, 511–520 (2015)
  Article CAS PubMed PubMed Central Google Scholar
• Kebede, M. A. & Attie, A. D. Insights into obesity and diabetes at the intersection of mouse and human genetics. Trends Endocrinol. Metab. 25, 493–501 (2014)
  Article CAS PubMed PubMed Central Google Scholar
• Ouchi, N. et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454–457 (2010)
  Article CAS PubMed PubMed Central ADS Google Scholar
• Fuster, J. J. et al. Non-canonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 64, 1235–1248 (2015)
  Article CAS PubMed Google Scholar
• Suzuki, K., Kumanogoh, A. & Kikutani, H. Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 9, 17–23 (2008)
  Article CAS PubMed Google Scholar
• Shimizu, I. et al. Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity. Cell Metab. 18, 491–504 (2013).This study illustrates a new mechanism that couples adipocytes and immune cells and impairs systemic insulin action and glucose metabolism through TNF-mediated inflammatory signals.
  Article CAS PubMed Google Scholar